+

WO2009034559A3 - Cosmetic process for aesthetic and/or repairing treatment of the skin - Google Patents

Cosmetic process for aesthetic and/or repairing treatment of the skin Download PDF

Info

Publication number
WO2009034559A3
WO2009034559A3 PCT/IB2008/053728 IB2008053728W WO2009034559A3 WO 2009034559 A3 WO2009034559 A3 WO 2009034559A3 IB 2008053728 W IB2008053728 W IB 2008053728W WO 2009034559 A3 WO2009034559 A3 WO 2009034559A3
Authority
WO
WIPO (PCT)
Prior art keywords
aesthetic
skin
cosmetic process
repairing treatment
individual
Prior art date
Application number
PCT/IB2008/053728
Other languages
French (fr)
Other versions
WO2009034559A2 (en
Inventor
Bris Benedicte Le
Pascale Pelletier
Corinne Granger
Catherine Marion
Original Assignee
Oreal
Bris Benedicte Le
Pascale Pelletier
Corinne Granger
Catherine Marion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal, Bris Benedicte Le, Pascale Pelletier, Corinne Granger, Catherine Marion filed Critical Oreal
Publication of WO2009034559A2 publication Critical patent/WO2009034559A2/en
Publication of WO2009034559A3 publication Critical patent/WO2009034559A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to a cosmetic process for aesthetic and/or repairing treatment of the skin of an individual, comprising at least one step of administering, to the said individual, according to a mesotherapy technique, a sterile fluid composition containing, in a physiologically acceptable medium, at least one C-glycoside derivative.
PCT/IB2008/053728 2007-09-14 2008-09-15 Cosmetic process for aesthetic and/or repairing treatment of the skin WO2009034559A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR0757558A FR2920968B1 (en) 2007-09-14 2007-09-14 COSMETIC PROCESS FOR AESTHETIC TREATMENT AND / OR REPAIR OF SKIN
FR0757558 2007-09-14
US97680107P 2007-10-02 2007-10-02
US60/976,801 2007-10-02

Publications (2)

Publication Number Publication Date
WO2009034559A2 WO2009034559A2 (en) 2009-03-19
WO2009034559A3 true WO2009034559A3 (en) 2009-06-25

Family

ID=39410184

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2008/053728 WO2009034559A2 (en) 2007-09-14 2008-09-15 Cosmetic process for aesthetic and/or repairing treatment of the skin

Country Status (2)

Country Link
FR (1) FR2920968B1 (en)
WO (1) WO2009034559A2 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2861734B1 (en) 2003-04-10 2006-04-14 Corneal Ind CROSSLINKING OF LOW AND HIGH MOLECULAR MASS POLYSACCHARIDES; PREPARATION OF INJECTABLE SINGLE PHASE HYDROGELS; POLYSACCHARIDES AND HYDROGELS OBTAINED
FR2902999B1 (en) 2006-07-03 2012-09-28 Oreal USE OF C-GLYCOSIDE DERIVATIVES AS PRODESQUAMANT INGREDIENTS
MX2010005331A (en) 2007-11-16 2010-08-11 Vicept Therapeutics Inc Compositions and methods for treating purpura.
US8394782B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
US8450475B2 (en) 2008-08-04 2013-05-28 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
EP3184552B1 (en) 2008-09-02 2020-08-12 Tautona Group LP Threads of hyaluronic acid, methods of making thereof and uses thereof
FR2940610B1 (en) * 2008-12-30 2011-05-06 Oreal ASSOCIATION OF MONOSACCHARIDES WITH C-GLYCOSIDE DERIVATIVES AND ITS USE IN COSMETICS
US9114188B2 (en) 2010-01-13 2015-08-25 Allergan, Industrie, S.A.S. Stable hydrogel compositions including additives
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
NZ602405A (en) 2010-03-12 2014-12-24 Allergan Ind Sas A fluid composition comprising a hyaluronan polymer and mannitol for improving skin conditions
EP2550027B2 (en) 2010-03-22 2019-03-20 Allergan, Inc. Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation
US8883139B2 (en) 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
US8889123B2 (en) 2010-08-19 2014-11-18 Allergan, Inc. Compositions and soft tissue replacement methods
US9005605B2 (en) 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
RU2740454C2 (en) 2011-06-03 2021-01-14 Аллерган Эндюстри, Сас Dermal filler compositions, including antioxidants
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
KR102387297B1 (en) * 2011-09-30 2022-04-15 엘라스타겐 피티와이 리미티드 In vivo synthesis of elastic fiber
WO2014063194A1 (en) 2012-10-23 2014-05-01 The University Of Sydney Elastic hydrogel
ES2860023T3 (en) 2012-12-10 2021-10-04 Allergan Pharmaceuticals Int Ltd Fabrication of scalable three-dimensional elastic constructs
JP6382311B2 (en) 2013-08-13 2018-08-29 エラスタジェン・プロプライエタリー・リミテッドＥｌａｓｔａｇｅｎ Ｐｔｙ Ｌｔｄ Regeneration of damaged tissue
ES2761558T3 (en) 2014-09-30 2020-05-20 Allergan Ind Sas Stable hydrogel compositions including additives
WO2016128783A1 (en) 2015-02-09 2016-08-18 Allergan Industrie Sas Compositions and methods for improving skin appearance
IL307979B1 (en) 2018-05-09 2025-04-01 Univ Johns Hopkins Nanofiber-hydrogel composites for enhanced soft tissue replacement and regeneration
AU2019267711B2 (en) 2018-05-09 2025-04-17 The Johns Hopkins University Nanofiber-hydrogel composites for cell and tissue delivery

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002051828A2 (en) * 2000-12-22 2002-07-04 L'oreal Novel c-glycoside derivatives and use thereof
FR2869317A1 (en) * 2004-04-23 2005-10-28 Oreal NOVEL C-GLYCOSIDE DERIVATIVES AND COSMETIC USES

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002051828A2 (en) * 2000-12-22 2002-07-04 L'oreal Novel c-glycoside derivatives and use thereof
FR2869317A1 (en) * 2004-04-23 2005-10-28 Oreal NOVEL C-GLYCOSIDE DERIVATIVES AND COSMETIC USES

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ANDRE P: "Hyaluronic acid and its use as a ''rejuvenation'' agent in cosmetic dermatology", SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, W.B. SAUNDERS, PHILADELPHIA, US, vol. 23, no. 4, 1 December 2004 (2004-12-01), pages 218 - 222, XP004700714, ISSN: 1085-5629 *
DATABASE EMBASE [online] ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL; July 2006 (2006-07-01), SINGH K: "Non surgical facial rejuvenation", XP002481857, Database accession no. EMB-2007217856 *
JOURNAL INTERNATIONAL MEDICAL SCIENCES ACADEMY 200607 IN, vol. 19, no. 3, July 2006 (2006-07-01), pages 158 - 164, ISSN: 0971-071X *

Also Published As

Publication number Publication date
WO2009034559A2 (en) 2009-03-19
FR2920968B1 (en) 2009-11-13
FR2920968A1 (en) 2009-03-20

Similar Documents

Publication Publication Date Title
WO2009034559A3 (en) Cosmetic process for aesthetic and/or repairing treatment of the skin
WO2009040420A3 (en) Use of a monoterpene to increase tissue repair
WO2009074735A8 (en) Use of a novel natural agent in cosmetic compositions
WO2006087759A3 (en) Pharmaceutical composition comprising curcumin and resveratrol and uses thereof in medical field
WO2007128817A3 (en) Insulin derivative
WO2007089454A3 (en) Methods for enhancing skin treatments
WO2008139122A3 (en) Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same
WO2009101503A3 (en) Use of natural active substances in cosmetic or therapeutic compositions
WO2008151749A3 (en) Activatable diagnostic and therapeutic compound
WO2009141541A3 (en) Use of kif13a and ap-1 inhibitors for inhibiting melanogenesis
EP2144608A4 (en) Sunscreen compositions and methods
WO2009125925A3 (en) Growth factor-mimicking peptides and uses thereof
WO2015031971A8 (en) A composition comprising guaçatonga extract and aroeira extract/ use thereof and a method for preventing and/or treating signals caused by skin aging
WO2013034855A3 (en) Combination of carrageenan and c-glycoside and uses thereof
WO2008107092A3 (en) Use of derivatives of 4-hydroxyphenoxy acetic acid
WO2008062467A3 (en) Cultured melanocytes on biopolymers
WO2008139123A3 (en) Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same
WO2008004165A3 (en) Use of c-glycoside derivatives as pro-desquamating active agents
MX2009003060A (en) Emulsion.
WO2007083006A3 (en) Use of an unsaponifiable extract of plant pulp in the treatment of skin ageing
WO2006131651A3 (en) Avermectin and hydrocortisone-based composition, in particular for roracea treatment
WO2014049561A3 (en) Oral composition for reinforcing skin tolerance following topical administration of a retinoid compound
WO2011073438A3 (en) Cosmetic method for treating body odours using a bacteriocin based composition
WO2009090085A8 (en) Abnormal intraocular pressure treatment
MX2009012712A (en) Novel 4-phenyl-imidazole-2-thiones used as tyrosinase inhibitors, method for preparing same and use thereof in human medicine and cosmetology.

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08807658

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 08807658

Country of ref document: EP

Kind code of ref document: A2

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载